Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Behjatolah Karbassi

Concepts (272)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
24
3.570
 Why?
Cancer Vaccines
13
2022
78
2.440
 Why?
Peptides
17
2022
239
2.360
 Why?
Carbohydrates
14
2009
41
2.210
 Why?
Molecular Mimicry
13
2007
35
1.870
 Why?
Breast Neoplasms
12
2024
1203
1.620
 Why?
Neoplasms
9
2022
1314
1.380
 Why?
Immunotherapy
6
2022
251
1.030
 Why?
Epitopes, T-Lymphocyte
6
2009
25
0.830
 Why?
HIV Envelope Protein gp120
4
2009
13
0.780
 Why?
Antibodies, Neoplasm
2
2017
27
0.750
 Why?
Lung Neoplasms
4
2014
643
0.750
 Why?
HIV-1
4
2009
60
0.750
 Why?
Mice, Inbred BALB C
16
2011
304
0.740
 Why?
Antigens
4
2003
41
0.720
 Why?
Animals
31
2023
13485
0.620
 Why?
Epithelial-Mesenchymal Transition
2
2020
56
0.600
 Why?
Clinical Trials, Phase I as Topic
2
2017
24
0.580
 Why?
Gene Expression Regulation, Neoplastic
5
2020
853
0.580
 Why?
Vaccines, DNA
6
2006
11
0.570
 Why?
Immunologic Surveillance
2
2009
10
0.570
 Why?
HIV Antigens
3
2006
9
0.540
 Why?
Epitopes
3
2009
62
0.530
 Why?
Cell Transformation, Neoplastic
1
2018
187
0.530
 Why?
Immunity, Innate
3
2018
109
0.500
 Why?
Antineoplastic Agents
3
2017
1216
0.500
 Why?
Neoplasm Proteins
1
2018
328
0.480
 Why?
Mice
20
2011
5899
0.480
 Why?
Molecular Targeted Therapy
1
2017
135
0.480
 Why?
Cell Hypoxia
1
2015
82
0.450
 Why?
Biomimetic Materials
1
2014
10
0.450
 Why?
Epigenesis, Genetic
1
2018
396
0.440
 Why?
Estrogen Receptor alpha
1
2015
86
0.440
 Why?
Vaccines
4
2002
47
0.420
 Why?
T-Lymphocytes
7
2010
318
0.420
 Why?
Cross Reactions
8
2006
43
0.410
 Why?
Oligosaccharides
4
2007
33
0.410
 Why?
Amino Acid Sequence
9
2006
576
0.410
 Why?
Molecular Sequence Data
9
2006
778
0.400
 Why?
Sarcoma, Experimental
2
2004
14
0.400
 Why?
Antigens, Neoplasm
5
2007
145
0.390
 Why?
Humans
35
2024
52441
0.390
 Why?
Polysaccharides
2
2011
58
0.390
 Why?
AIDS Vaccines
3
2009
11
0.370
 Why?
Plant Lectins
2
2010
8
0.370
 Why?
Isoflavones
1
2023
92
0.370
 Why?
Sulfotransferases
3
2020
38
0.360
 Why?
Chondroitin Sulfates
2
2011
14
0.350
 Why?
P-Selectin
2
2011
27
0.350
 Why?
Soybean Proteins
1
2023
168
0.350
 Why?
CD8-Positive T-Lymphocytes
3
2007
140
0.340
 Why?
Autoantigens
1
2011
47
0.340
 Why?
Fructose
1
2010
21
0.330
 Why?
Adaptive Immunity
1
2010
34
0.330
 Why?
Carbon
1
2010
60
0.320
 Why?
CD4-Positive T-Lymphocytes
3
2006
165
0.310
 Why?
Vaccines, Subunit
3
2006
15
0.310
 Why?
Obesity
2
2023
1176
0.310
 Why?
Drug Delivery Systems
1
2010
148
0.290
 Why?
Carcinoma, Ductal
1
2008
7
0.290
 Why?
Proteoglycans
3
2023
86
0.280
 Why?
Mammary Neoplasms, Experimental
2
2005
122
0.280
 Why?
Interferon-gamma
4
2018
169
0.270
 Why?
Carcinoma in Situ
1
2008
72
0.270
 Why?
Cell Line, Tumor
6
2011
1429
0.270
 Why?
Dendritic Cells
3
2005
132
0.260
 Why?
T-Lymphocytes, Cytotoxic
5
2009
64
0.260
 Why?
Female
18
2024
28277
0.250
 Why?
Concanavalin A
2
2005
10
0.240
 Why?
Sarcoma
1
2006
68
0.230
 Why?
Mammary Neoplasms, Animal
1
2005
33
0.230
 Why?
HIV Infections
1
2009
394
0.230
 Why?
Ligands
5
2011
205
0.230
 Why?
MCF-7 Cells
4
2020
63
0.220
 Why?
Neoplasm Metastasis
5
2015
235
0.220
 Why?
Magnetic Resonance Spectroscopy
1
2005
249
0.220
 Why?
Acetylglucosamine
1
2004
7
0.220
 Why?
Histocompatibility Antigens Class I
1
2004
47
0.210
 Why?
Combined Modality Therapy
2
2017
641
0.210
 Why?
Melanoma
1
2007
272
0.210
 Why?
Immunoglobulin G
2
2003
193
0.200
 Why?
Immunotherapy, Active
1
2003
4
0.200
 Why?
Peptide Fragments
1
2004
214
0.200
 Why?
Peptide Library
4
2005
16
0.200
 Why?
Cell Proliferation
4
2020
1013
0.190
 Why?
Glycosylation
3
2010
104
0.190
 Why?
Autoantibodies
2
2018
118
0.190
 Why?
Antigens, Viral
1
2002
44
0.190
 Why?
Antibodies, Monoclonal
5
2023
475
0.190
 Why?
Apoptosis
2
2020
1120
0.190
 Why?
Biochemistry
1
2001
6
0.180
 Why?
Liver Neoplasms
1
2005
341
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
234
0.180
 Why?
Cell Adhesion
3
2006
162
0.170
 Why?
Carbamates
1
2020
15
0.160
 Why?
CHO Cells
3
2006
123
0.160
 Why?
Cricetinae
3
2006
189
0.160
 Why?
Adjuvants, Immunologic
2
2014
51
0.160
 Why?
Colchicine
1
2020
24
0.160
 Why?
Antineoplastic Agents, Phytogenic
1
2020
71
0.160
 Why?
Neoplastic Stem Cells
1
2020
88
0.150
 Why?
Carcinoma, Ductal, Breast
1
2020
89
0.150
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
90
0.150
 Why?
Anthroposophy
1
2018
1
0.140
 Why?
Flow Cytometry
3
2006
396
0.140
 Why?
Tumor Cells, Cultured
3
2015
441
0.140
 Why?
Tumor Microenvironment
2
2024
257
0.140
 Why?
Antibody Formation
3
2003
51
0.140
 Why?
Cell Division
3
2006
288
0.140
 Why?
Gene-Environment Interaction
1
2018
41
0.140
 Why?
Immunization
3
2004
69
0.140
 Why?
Immune Tolerance
2
2009
91
0.140
 Why?
Chondroitin Sulfate Proteoglycans
2
2023
18
0.140
 Why?
Plant Extracts
1
2020
199
0.140
 Why?
Cell Movement
4
2020
271
0.130
 Why?
Spleen
3
2004
166
0.130
 Why?
Homeostasis
1
2018
206
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.130
 Why?
Forecasting
1
2017
151
0.120
 Why?
HIV Antibodies
2
2006
15
0.120
 Why?
Models, Immunological
2
2007
8
0.120
 Why?
Membrane Proteins
2
2023
344
0.120
 Why?
Interleukin-12
2
2006
26
0.110
 Why?
Lectins
2
2006
14
0.110
 Why?
Phenotype
2
2010
792
0.110
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
60
0.110
 Why?
Coculture Techniques
1
2015
142
0.110
 Why?
Drug Therapy
1
2014
46
0.110
 Why?
Transforming Growth Factor beta
1
2015
136
0.110
 Why?
Antibodies
1
2014
144
0.110
 Why?
Adipocytes
1
2015
127
0.110
 Why?
Nuclear Proteins
1
2015
247
0.100
 Why?
Vaccines, Conjugate
2
2005
9
0.100
 Why?
Cell Separation
2
2005
78
0.100
 Why?
Scavenger Receptors, Class E
1
2015
200
0.100
 Why?
Rats, Zucker
1
2023
73
0.100
 Why?
Positron-Emission Tomography
1
2014
297
0.100
 Why?
Cytotoxicity, Immunologic
2
2005
55
0.100
 Why?
Mutation
1
2018
1331
0.090
 Why?
Protein Binding
2
2005
673
0.090
 Why?
Mice, Nude
2
2004
230
0.090
 Why?
Immunity, Cellular
2
2003
64
0.090
 Why?
C-Reactive Protein
1
2023
151
0.090
 Why?
Lymphocyte Activation
3
2001
161
0.090
 Why?
Kinetics
2
2005
613
0.090
 Why?
Injections, Intramuscular
2
2003
57
0.090
 Why?
Interleukin-6
1
2023
271
0.090
 Why?
Binding Sites
2
2003
379
0.090
 Why?
Prognosis
3
2020
2100
0.090
 Why?
Lung
1
2014
479
0.090
 Why?
Tumor Necrosis Factor-alpha
1
2023
390
0.090
 Why?
Microscopy, Phase-Contrast
1
2010
9
0.080
 Why?
DNA Methylation
1
2015
573
0.080
 Why?
Body Weight
1
2023
524
0.080
 Why?
Transfection
3
2007
365
0.080
 Why?
B-Lymphocytes
2
2002
178
0.080
 Why?
Antigens, CD
2
2003
213
0.080
 Why?
Substrate Specificity
1
2010
197
0.080
 Why?
Membrane Glycoproteins
2
2003
239
0.080
 Why?
Actins
1
2010
112
0.080
 Why?
Dose-Response Relationship, Drug
2
2005
1365
0.080
 Why?
Antibodies, Catalytic
1
2009
1
0.080
 Why?
Receptors, CCR5
1
2009
7
0.080
 Why?
Neoplasm Invasiveness
1
2010
278
0.080
 Why?
Cells, Cultured
2
2003
1583
0.070
 Why?
Time Factors
2
2005
2987
0.070
 Why?
Killer Cells, Natural
1
2009
111
0.070
 Why?
Fucosyltransferases
1
2007
5
0.070
 Why?
Male
3
2023
26874
0.070
 Why?
Glycosaminoglycans
1
2007
19
0.070
 Why?
Molecular Biology
1
2007
27
0.060
 Why?
Binding Sites, Antibody
1
2006
14
0.060
 Why?
Rats
1
2023
3228
0.060
 Why?
Amino Acid Motifs
1
2006
59
0.060
 Why?
Heparin
1
2007
88
0.060
 Why?
Cricetulus
1
2006
100
0.060
 Why?
Cell Membrane
1
2007
238
0.060
 Why?
Antineoplastic Agents, Alkylating
1
2006
78
0.060
 Why?
E-Selectin
1
2005
11
0.060
 Why?
Xenograft Model Antitumor Assays
1
2006
218
0.060
 Why?
Mannose
1
2005
12
0.060
 Why?
Wheat Germ Agglutinins
1
2005
3
0.060
 Why?
Densitometry
1
2005
13
0.060
 Why?
Hydrocarbons
1
2005
14
0.060
 Why?
Cyclophosphamide
1
2006
176
0.060
 Why?
Surface Plasmon Resonance
1
2005
19
0.060
 Why?
Methane
1
2005
10
0.060
 Why?
Phosphorylcholine
1
2005
19
0.060
 Why?
Bone Marrow Cells
1
2006
188
0.060
 Why?
Growth Inhibitors
1
2005
26
0.060
 Why?
Biosensing Techniques
1
2005
31
0.060
 Why?
Calcium
1
2007
396
0.060
 Why?
Immunoglobulins
1
2005
76
0.060
 Why?
Glycolysis
1
2005
70
0.060
 Why?
Genetic Variation
1
2006
226
0.060
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
412
0.060
 Why?
Antigen Presentation
1
2004
25
0.050
 Why?
Bone Neoplasms
1
2006
188
0.050
 Why?
Treatment Outcome
1
2014
5508
0.050
 Why?
Endothelial Cells
1
2006
283
0.050
 Why?
Cytosol
1
2004
82
0.050
 Why?
Plasmids
2
2003
162
0.050
 Why?
Immunoglobulin Constant Regions
1
2003
3
0.050
 Why?
Recombinant Proteins
1
2005
490
0.050
 Why?
Middle Aged
2
2020
13133
0.050
 Why?
Histocompatibility Antigens Class II
1
2003
35
0.050
 Why?
Bacterial Capsules
1
2003
15
0.050
 Why?
Antibodies, Viral
1
2003
113
0.050
 Why?
Immunoglobulin M
1
2003
59
0.050
 Why?
DNA, Neoplasm
1
2003
146
0.050
 Why?
Th1 Cells
1
2003
51
0.050
 Why?
Carbohydrate Metabolism
1
2002
25
0.050
 Why?
Antibodies, Anti-Idiotypic
1
2002
23
0.050
 Why?
Models, Chemical
1
2002
65
0.050
 Why?
L-Selectin
1
2001
6
0.050
 Why?
Calorimetry
1
2001
6
0.040
 Why?
Carbohydrate Sequence
1
2001
7
0.040
 Why?
Epitope Mapping
1
2001
6
0.040
 Why?
Thermodynamics
1
2001
34
0.040
 Why?
Binding, Competitive
1
2001
92
0.040
 Why?
Mice, Inbred CBA
1
2001
37
0.040
 Why?
Protein Structure, Secondary
1
2001
73
0.040
 Why?
Sequence Homology, Amino Acid
1
2001
140
0.040
 Why?
Gene Expression Profiling
1
2006
1099
0.040
 Why?
Protein Conformation
1
2001
178
0.040
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
11
0.040
 Why?
Injections, Intraperitoneal
1
2000
55
0.040
 Why?
Colchicum
1
2020
3
0.040
 Why?
Inhibitory Concentration 50
1
2020
74
0.040
 Why?
Models, Molecular
1
2001
356
0.040
 Why?
Drug Screening Assays, Antitumor
1
2020
135
0.040
 Why?
Child, Preschool
1
2008
4046
0.040
 Why?
Wnt Signaling Pathway
1
2020
96
0.040
 Why?
H-2 Antigens
1
1999
3
0.040
 Why?
Receptors, Estrogen
1
2020
133
0.040
 Why?
Transformation, Genetic
1
1998
17
0.040
 Why?
Glycoside Hydrolases
1
1998
16
0.040
 Why?
Clostridium
1
1998
17
0.040
 Why?
Cell Survival
1
2020
598
0.040
 Why?
Genes, Reporter
1
1998
86
0.030
 Why?
Plants
1
1998
28
0.030
 Why?
Models, Biological
1
2001
735
0.030
 Why?
Survival Rate
1
2020
944
0.030
 Why?
Adolescent
1
2008
6713
0.030
 Why?
Retrospective Studies
1
2008
6694
0.030
 Why?
Child
1
2008
7194
0.030
 Why?
CpG Islands
1
2015
111
0.030
 Why?
Disease Progression
1
2015
870
0.020
 Why?
RNA Interference
1
2011
183
0.020
 Why?
RNA, Small Interfering
1
2011
217
0.020
 Why?
Simian virus 40
1
2003
12
0.010
 Why?
Lymphocyte Subsets
1
2003
14
0.010
 Why?
Immunoglobulin Variable Region
1
2003
16
0.010
 Why?
Mutagenesis, Site-Directed
1
2003
100
0.010
 Why?
Sequence Deletion
1
2003
69
0.010
 Why?
Protein Structure, Tertiary
1
2003
260
0.010
 Why?
Recombinant Fusion Proteins
1
2003
177
0.010
 Why?
Down-Regulation
1
2003
348
0.010
 Why?
Up-Regulation
1
2003
462
0.010
 Why?
HIV Envelope Protein gp160
1
1999
2
0.010
 Why?
Radiation Chimera
1
1999
4
0.010
 Why?
Protein Engineering
1
1999
18
0.010
 Why?
beta 2-Microglobulin
1
1999
39
0.010
 Why?
Plants, Toxic
1
1998
10
0.010
 Why?
Enzyme Stability
1
1998
21
0.010
 Why?
Plants, Genetically Modified
1
1998
19
0.010
 Why?
Stem Cells
1
1999
186
0.010
 Why?
Hot Temperature
1
1998
203
0.010
 Why?
Signal Transduction
1
2003
1724
0.010
 Why?
Mice, Knockout
1
1999
903
0.010
 Why?
Mice, Inbred C57BL
1
1999
1888
0.010
 Why?
Muscle, Skeletal
1
1999
799
0.010
 Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (272) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department